CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology® (CST) where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Novel Therapeutic Approaches for Diffuse Large B Cell Lymphoma

Lymphoma is a cancer of the lymphatic system, a principal part of the body’s immune system. Lymphoma...
Andrea T May 11, 2022 3:00:00 AM

Melanoma: Aberrant Signaling Pathways and Therapeutic Approaches

There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melan...
Andrea T Mar 30, 2022 3:00:00 AM

The Top Emerging Therapeutic Approaches for Prostate Cancer

Approximately 1 in 8 men will be diagnosed with prostate cancer, a disease which accounts for the se...
Andrea T Feb 23, 2022 3:00:00 AM

The Importance of ISG15 in Covid Research

Historically, the ISG15 protein hasn’t been thoroughly investigated by researchers. We know it can f...
Francesco P Feb 9, 2022 3:00:00 AM

Targeting TIGIT for Immunotherapy and T Cell Exhaustion

The evolution of solid tumor cancer treatment has historically centered on a tripartite approach tha...
Tamar A. Feb 17, 2021 3:00:00 AM

Tools to Help Researchers Fight COVID-19

In order to quickly defeat SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2,previously na...
Maxine M Feb 26, 2020 3:15:00 AM

Targeting B-Cell Maturation Antigen (BCMA) Holds Promise for Multiple Myeloma Cure

Multiple myeloma (MM) is a type of hematopoietic malignancy characterized, in part, by bone pain, an...
Amrik S. Aug 8, 2018 3:10:00 AM

Still in the Dark: AMD Patients Wait for Answers

In Mr. D’s sophomore English class, almost no subject was taboo or off limits. Even with our class p...
Chris S Apr 11, 2018 3:15:00 AM

GPNMB: A Promising Immunotherapeutic Target for Triple Negative Breast Cancer

The last few years have witnessed several breakthroughs in the immuno-oncology space. Treatments tha...
Amrik S. Apr 4, 2018 3:00:00 AM

Immunotherapy: Empowering Nature’s Anti-Tumor Artillery - Part I

If you happened to attend AACR, AAI, or ASCO this year you’d agree that immune cell-based cancer the...
Liana G Jan 27, 2016 3:00:00 AM
    Content not found

    Related Posts